US2020023000A1PendingUtilityA1

Synergism of gos and polyfructose

63
Assignee: NUTRICIA NVPriority: May 17, 2004Filed: Sep 27, 2019Published: Jan 23, 2020
Est. expiryMay 17, 2024(expired)· nominal 20-yr term from priority
Inventors:Gelske SpeelmansMaria Johanna Adriana Petronella GoversJan KnolEric Alexander Franciscus Van Tol
A61P 37/08A61P 29/00A61P 3/02A61P 1/06A61P 21/02A61P 1/00A61P 1/04A61P 1/10A61P 1/14A61P 17/00A61K 31/702A23L 29/30A61K 31/715A23V 2002/00A23V 2200/318A23L 33/125A23L 33/40A23L 33/10A61K 31/01A23L 7/00A23L 29/244A23L 5/00A61K 31/733A23L 33/22
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the field of prebiotics. Provided are uses for compositions comprising synergistically effective amounts of polyfructose and galactooligosaccharides (GOS).

Claims

exact text as granted — not AI-modified
1 . A method of treating allergy, the method consisting of orally administering to a mammal suffering from allergy a composition comprising galactooligosaccharide and polyfructose, wherein the weight ratio of galactooligosaccharide:polyfructose is 97:3 to 80:20, and wherein the composition does not comprise lactobacilli and bifidobacteria. 
     
     
         2 . The method according to  claim 1 , wherein the weight ratio of galactooligosaccharide:polyfructose is 95:5 to 85:15. 
     
     
         3 . The method according to  claim 2 , wherein the weight ratio of galactooligosaccharide:polyfructose is about 90:10. 
     
     
         4 . The method according to  claim 1 , wherein the galactooligosaccharide is transgalacto-oligosaccharide. 
     
     
         5 . The method according to  claim 1 , wherein the polyfructose is inulin. 
     
     
         6 . The method according to  claim 1 , wherein the galactooligosaccharide is transgalacto-oligosaccharide and the polyfructose is inulin. 
     
     
         7 . The method according to  claim 5 , wherein the inulin has an average degree of polymerization of 20 to 150. 
     
     
         8 . The method according to  claim 6 , wherein the inulin has an average degree of polymerization of 20 to 150. 
     
     
         9 . The method according to  claim 1 , wherein the composition is liquid. 
     
     
         10 . The method according to  claim 1 , wherein the mammal is a human child, teenager or adult. 
     
     
         11 . The method according to  claim 1 , wherein the mammal is a human infant. 
     
     
         12 . The method according to  claim 11 , wherein the human infant is up to a 12 months old infant.

Join the waitlist — get patent alerts

Track US2020023000A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.